Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis

Translational Research

Volumn 166, Issue 6, 2015, Pages 554-567

  Tashiro, Jun ^a   Elliot, Sharon J ^a   Gerth, David J ^a   Xia, Xiaomei ^a   Pereira Simon, Simone ^a   Choi, Rhea ^a   Catanuto, Paola ^a   Shahzeidi, Shahriar ^a   Toonkel, Rebecca L ^b   Shah, Rahil H ^a   El Salem, Fadi ^c   Glassberg, Marilyn K ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BIOLOGICAL MARKER; BLEOMYCIN; CASPASE 9; COLLAGEN; GELATINASE A; MESSENGER RNA; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN RECEPTOR; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASHCROFT SCORE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; BONE DEVELOPMENT; CELL AGING; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; LUNG PARENCHYMA; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; ADIPOSE TISSUE; AGE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PULMONARY FIBROSIS; TUNEL ASSAY;

ADIPOSE TISSUE; AGE FACTORS; ANIMALS; BIOMARKERS; BLEOMYCIN; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; IN SITU NICK-END LABELING; MALE; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY FIBROSIS;

EID: 84958029950     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.09.004     Document Type: Article

References (61)

1. G. Raghu, H.R. Collard, J.J. Egan, and et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
2. I.E. Fernandez, and O. Eickelberg New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis Lancet 380 2012 680 688
3. G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, and G. Oster Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 2006 810 816
4. G.M. Hunninghake A new hope for idiopathic pulmonary fibrosis N Engl J Med 370 2014 2142 2143
5. G. Izbicki, M.J. Segel, T.G. Christensen, M.W. Conner, and R. Breuer Time course of bleomycin-induced lung fibrosis Int J Exp Pathol 83 2002 111 119
6. L.A. Ortiz, F. Gambelli, C. McBride, and et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects Proc Natl Acad Sci USA 100 2003 8407 8411
7. M. Rojas, J. Xu, C.R. Woods, and et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung Am J Respir Cell Mol Biol 33 2005 145 152
8. N.I. Chaudhary, A. Schnapp, and J.E. Park Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model Am J Respir Crit Care Med 173 2006 769 776
9. L.A. Ortiz, M. Dutreil, C. Fattman, and et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury Proc Natl Acad Sci USA 104 2007 11002 11007
10. S. Aguilar, C.J. Scotton, K. McNulty, and et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis PLoS One 4 2009 e8013
11. A.L. Degryse, H. Tanjore, X.C. Xu, and et al. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol 299 2010 L442 L452
12. E.F. Redente, K.M. Jacobsen, J.J. Solomon, and et al. Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis Am J Physiol Lung Cell Mol Physiol 301 2011 L510 L518
13. V. Sueblinvong, D.C. Neujahr, S.T. Mills, and et al. Predisposition for disrepair in the aged lung Am J Med Sci 344 2012 41 51
14. A.M. Foskett, N. Bazhanov, X. Ti, and et al. Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs Am J Physiol Lung Cell Mol Physiol 306 2014 L120 L131
15. H.G. Leach, I. Chrobak, R. Han, and M. Trojanowska Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury Am J Respir Cell Mol Biol 49 2013 1093 1101
16. L. Hecker, N.J. Logsdon, D. Kurundkar, and et al. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance Sci Transl Med 6 2014 231ra47
17. R. Peng, S. Sridhar, G. Tyagi, and et al. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: A model for "active" disease PLoS One 8 2013 e59348
18. E.F. Redente, R.C. Keith, W. Janssen, and et al. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages Am J Respir Cell Mol Biol 50 2014 825 837
19. M.L. Bustos, L. Huleihel, M.G. Kapetanaki, and et al. Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response Am J Respir Crit Care Med 189 2014 787 798
20. C.E. Barkauskas, M.J. Cronce, C.R. Rackley, and et al. Type 2 alveolar cells are stem cells in adult lung J Clin Invest 123 2013 3025 3036
21. M. Selman, and A. Pardo Role of epithelial cells in idiopathic pulmonary fibrosis: From innocent targets to serial killers Proc Am Thorac Soc 3 2006 364 372
22. L. Richeldi, R.M. du Bois, G. Raghu, and et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis N Engl J Med 370 2014 2071 2082
23. D.N. Kotton, and E.E. Morrisey Lung regeneration: Mechanisms, applications and emerging stem cell populations Nat Med 20 2014 822 832
24. K. Huang, X. Kang, X. Wang, and et al. Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats Mol Med Rep 11 2015 1685 1692
25. O. Garcia, G. Carraro, G. Turcatel, and et al. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage PLoS One 8 2013 e71679
26. S.A. Villeda, K.E. Plambeck, J. Middeldorp, and et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice Nat Med 20 2014 659 663
27. S.M. Paul, and K. Reddy Young blood rejuvenates old brains Nat Med 20 2014 582 583
28. Z. Feng, A.R. Plati, Q.L. Cheng, and et al. Glomerular aging in females is a multi-stage reversible process mediated by phenotypic changes in progenitors Am J Pathol 167 2005 355 363
29. K. Furuichi, H. Shintani, Y. Sakai, and et al. Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney Clin Exp Nephrol 16 2012 679 689
30. S. Saito, T. Nakayama, N. Hashimoto, and et al. Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage Am J Pathol 179 2011 1088 1094
31. Q. Wang, H. Zhu, W.G. Zhou, and et al. N-acetylcysteine-pretreated human embryonic mesenchymal stem cell administration protects against bleomycin-induced lung injury Am J Med Sci 346 2013 113 122
32. T. Ashcroft, J.M. Simpson, and V. Timbrell Simple method of estimating severity of pulmonary fibrosis on a numerical scale J Clin Pathol 41 1988 467 470
33. M. Karl, M. Berho, J. Pignac-Kobinger, G.E. Striker, and S.J. Elliot Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: Modulation of the mesangial cell phenotype in vivo Am J Pathol 169 2006 351 361
34. M. Potier, M. Karl, F. Zheng, and et al. Estrogen-related abnormalities in glomerulosclerosis-prone mice: Reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens Am J Pathol 160 2002 1877 1885
35. M.K. Glassberg, R. Choi, V. Manzoli, and et al. 17beta-estradiol replacement reverses age-related lung disease in estrogen-deficient C57BL/6J mice Endocrinology 155 2014 441 448
36. N.C. Henderson, T.D. Arnold, Y. Katamura, and et al. Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs Nat Med 19 2013 1617 1624
37. V. Sueblinvong, W.A. Neveu, D.C. Neujahr, and et al. Aging promotes pro-fibrotic matrix production and increases fibrocyte recruitment during acute lung injury Adv Biosci Biotechnol 5 2014 19 30
38. M.W. Parker, D. Rossi, M. Peterson, and et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop J Clin Invest 124 2014 1622 1635
39. M.P. Chung, M.M. Monick, N.Y. Hamzeh, and et al. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis Am J Respir Cell Mol Biol 29 2003 375 380
40. S.H. Lee, E.J. Lee, S.Y. Lee, and et al. The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice Exp Lung Res 40 2014 117 125
41. A. Cargnoni, L. Gibelli, A. Tosini, and et al. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis Cell Transplant 18 2009 405 422
42. Y. Moodley, D. Atienza, U. Manuelpillai, and et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury Am J Pathol 175 2009 303 313
43. S.A. Park, M.J. Kim, S.Y. Park, and et al. EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling Cell Mol Life Sci 72 2015 2023 2039
44. T. Nkyimbeng, C. Ruppert, T. Shiomi, and et al. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis PLoS One 8 2013 e73279
45. M.G. Kapetanaki, A.L. Mora, and M. Rojas Influence of age on wound healing and fibrosis J Pathol 229 2013 310 322
46. S.J. Elliot, P. Catanuto, D.G. Espinosa-Heidmann, and et al. Estrogen receptor beta protects against in vivo injury in RPE cells Exp Eye Res 90 2010 10 16
47. M.K. Glassberg, S.J. Elliot, J. Fritz, and et al. Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness J Clin Endocrinol Metab 93 2008 1625 1633
48. N. Kassira, M.K. Glassberg, C. Jones, and et al. Estrogen deficiency and tobacco smoke exposure promote matrix metalloproteinase-13 activation in skin of aging B6 mice Ann Plast Surg 63 2009 318 322
49. Y. Cai, L. Zhu, F. Zhang, and et al. Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs) Mol Pharm 10 2013 2237 2247
50. A. Knoblauch, C. Will, G. Goncharenko, S. Ludwig, and V. Wixler The binding of Mss4 to alpha-integrin subunits regulates matrix metalloproteinase activation and fibronectin remodeling FASEB J 21 2007 497 510
51. G. Rajashekhar, M. Shivanna, U.B. Kompella, Y. Wang, and S.P. Srinivas Role of MMP-9 in the breakdown of barrier integrity of the corneal endothelium in response to TNF-α Exp Eye Res 122 2014 77 85
52. S. Choo, D. Papandria, Y. Zhang, and et al. Outcomes analysis after percutaneous abdominal drainage and exploratory laparotomy for necrotizing enterocolitis in 4,657 infants Pediatr Surg Int 27 2011 747 753
53. R.C. Russo, C.C. Garcia, L.S. Barcelos, and et al. Phosphoinositide 3-kinase gamma plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice J Leukoc Biol 89 2011 269 282
54. S. Park, J.Y. Ahn, M.J. Lim, and et al. Sustained expression of NADPH oxidase 4 by p38 MAPK-Akt signaling potentiates radiation-induced differentiation of lung fibroblasts J Mol Med (Berl) 88 2010 807 816
55. P. Cheresh, S.J. Kim, S. Tulasiram, and D.W. Kamp Oxidative stress and pulmonary fibrosis Biochim Biophys Acta 1832 2013 1028 1040
56. K.K. Nelson, and J.A. Melendez Mitochondrial redox control of matrix metalloproteinases Free Radic Biol Med 37 2004 768 784
57. N.J. Smith, H.W. Chan, J.E. Osborne, W.G. Thomas, and R.D. Hannan Hijacking epidermal growth factor receptors by angiotensin II: New possibilities for understanding and treating cardiac hypertrophy Cell Mol Life Sci 61 2004 2695 2703
58. P.D. Ray, B.W. Huang, and Y. Tsuji Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling Cell Signal 24 2012 981 990
59. E.R. Stadtman Role of oxidant species in aging Curr Med Chem 11 2004 1105 1112
60. H.B. Schiller, I.E. Fernandez, G. Burgstaller, and et al. Time- A nd compartment-resolved proteome profiling of the extracellular niche in lung injury and repair Mol Syst Biol 11 2015 819
61. K. Tatsumi, K. Ohashi, Y. Matsubara, and et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism Biochem Biophys Res Commun 431 2013 203 209